You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Europe Wrist Replacement Devices Market The report “European Wrist Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Wrist Implant and Total Wrist Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Wrist osteoarthritis and rheumatoid arthritis. |
Upcoming |
|
|
Asia Wrist Replacement Devices Market The report “Asian Wrist Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Wrist Implant and Total Wrist Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Wrist osteoarthritis and rheumatoid arthritis. |
Upcoming |
|
|
Asia Digit Replacement Devices Market The report “Asian Digits Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Digits Replacement Implant & Devices, Digit Prosthetics and Digits Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Digits osteoarthritis and rheumatoid arthritis |
Upcoming |
|
|
Europe Digit Replacement Devices Market The report “European Digits Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Digits Replacement Implant & Devices, Digit Prosthetics and Digits Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Digits osteoarthritis and rheumatoid arthritis. |
Upcoming |
|
|
North America Digit Replacement Devices Market The report “North American Digits Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Digits Replacement Implant & Devices, Digit Prosthetics and Digits Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Digits osteoarthritis and rheumatoid arthritis. |
Upcoming |
|
|
Asia Spine Biologics Market The report “The Asian Spine Biologics market forecast 2012-2014” analyzes the market by technology devices into 5 segments such as Spinal Allograft, Demineralized Bone Matrix, Bone Morphogenetic Proteins, Bone Substitutes and Machined Bones. ... |
Upcoming |
|
|
Europe Spine Biologics Market The report “The European Spine Biologics market forecast 2012-2014” analyzes the market by technology devices into 5 segments such as Spinal Allograft, Demineralized Bone Matrix, Bone Morphogenetic Proteins, Bone Substitutes and Machined Bones. |
Upcoming |
|
|
North America Spine Biologics Market The report “The North American Spine Biologics market forecast 2012-2014” analyzes the market by technology devices into 5 segments such as Spinal Allograft, Demineralized Bone Matrix, Bone Morphogenetic Proteins, Bone Substitutes and Machined Bones Some of the key players in The North American Spine Biologics market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
North American Nasal Drug Delivery Market The North American Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.49 billion in 2013 and expected to be $6.62 billion by 2018, growing at a CAGR of 8.1%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
European Nasal Drug Delivery Market The European Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.95 billion in 2013 and expected to be $4.14 billion by 2018, growing at a CAGR of 7.0%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
Asian Nasal Drug Delivery Market The Asian Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.51 billion in 2013 and expected to be $2.69 billion by 2018, growing at a CAGR of 12.2%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
North American Transmucosal Drug Delivery Market The North American Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.26 billion in 2013 and expected to be $1.70 billion by 2018, growing at a CAGR of 6.2%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs. |
Upcoming |
|
|
European Transmucosal Drug Delivery Market The European Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $0.81 billion in 2013 and expected to be $1.07 billion by 2018, growing at a CAGR of 5.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs. |
Upcoming |
|
|
Asian Transmucosal Drug Delivery Market The Asian Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $0.48 billion in 2013 and expected to be $0.72 billion by 2018, growing at a CAGR of 8.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs. |
Upcoming |
|
|
Asian Topical Drug Delivery Market The Asian Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.54 billion in 2013 and expected to be $2.10 billion by 2018, growing at a CAGR of 6.4%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc. |
Upcoming |
|
|
European Topical Drug Delivery Market The European Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.64 billion in 2013 and expected to be $2.96 billion by 2018, growing at a CAGR of 2.3%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc. |
Upcoming |
|
|
North American Topical Drug Delivery Market The North American Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.23 billion in 2013 and expected to be $4.90 billion by 2018, growing at a CAGR of 3.0%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc. |
Upcoming |
|
|
Asia Cervical Fusion Market The report “The Asian Cervical Fusion devices market forecast 2012-2018” analyzes the market of devices by 3 segments such as Anterior Cervical Fusion, Posterior Cervical Fusion and Inter-body Cervical Fusion. Some of the key players in the Asian Cervical Fusion market include Synthes, Stryker, DePuy, Medtronic, and NuVasive and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Europe Cervical Fusion Market The report “The European Cervical Fusion devices market forecast 2012-2018” analyzes the market of devices by 3 segments such as Anterior Cervical Fusion, Posterior Cervical Fusion and Inter-body Cervical Fusion. Some of the key players in the European Cervical Fusion market include Synthes, Stryker, DePuy, Medtronic, and NuVasive and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
North America Cervical Fusion Market The report “The North AmericanCervical Fusion devices market forecast 2012-2018” analyzes the market of devices by 3 segments such as Anterior Cervical Fusion, Posterior Cervical Fusion and Inter-body Cervical Fusion. Some of the key players in the North American Cervical Fusion market include Synthes, Stryker, DePuy, Medtronic, and NuVasive and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
Healthcare
